70 related articles for article (PubMed ID: 16720266)
1. trans-Platinum reporting for duty.
Burdette S
Chem Biol; 2006 May; 13(5):465-7. PubMed ID: 16720266
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
Rice WG; Turpin JA; Schaeffer CA; Graham L; Clanton D; Buckheit RW; Zaharevitz D; Summers MF; Wallqvist A; Covell DG
J Med Chem; 1996 Sep; 39(19):3606-16. PubMed ID: 8809151
[TBL] [Abstract][Full Text] [Related]
3. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the chemical and biological properties of trans platinum complexes: monofunctional platinum complexes containing one nucleobase as potential antiviral chemotypes.
Sartori DA; Miller B; Biebach U; Farrell N
J Biol Inorg Chem; 2000 Oct; 5(5):575-83. PubMed ID: 11085648
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
7. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
Cao YL; Guo Y
Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
[TBL] [Abstract][Full Text] [Related]
8. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
[TBL] [Abstract][Full Text] [Related]
9. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy.
de Rocquigny H; Shvadchak V; Avilov S; Dong CZ; Dietrich U; Darlix JL; Mély Y
Mini Rev Med Chem; 2008 Jan; 8(1):24-35. PubMed ID: 18220982
[TBL] [Abstract][Full Text] [Related]
10. Prevention of HIV-1 infection by platinum triazines.
Vzorov AN; Bhattacharyya D; Marzilli LG; Compans RW
Antiviral Res; 2005 Feb; 65(2):57-67. PubMed ID: 15708632
[TBL] [Abstract][Full Text] [Related]
11. Anti-AIDS agents 66: syntheses and anti-HIV activity of phenolic and aza 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives.
Suzuki M; Yu D; Morris-Natschke SL; Smith PC; Lee KH
Bioorg Med Chem; 2007 Nov; 15(21):6852-8. PubMed ID: 17719228
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 replication by long-term treatment with a chimeric RNA containing shRNA and TAR decoy RNA.
Barnor JS; Habu Y; Yamamoto N; Miyano-Kurosaki N; Ishikawa K; Yamamoto N; Takaku H
Antiviral Res; 2009 Aug; 83(2):156-64. PubMed ID: 19397929
[TBL] [Abstract][Full Text] [Related]
13. Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway.
Hu Q; Younson J; Griffin GE; Kelly C; Shattock RJ
J Infect Dis; 2006 Dec; 194(11):1547-56. PubMed ID: 17083039
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists.
Habashita H; Kokubo M; Hamano S; Hamanaka N; Toda M; Shibayama S; Tada H; Sagawa K; Fukushima D; Maeda K; Mitsuya H
J Med Chem; 2006 Jul; 49(14):4140-52. PubMed ID: 16821774
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound.
Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D
Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
Garcia JM; Gao A; He PL; Choi J; Tang W; Bruzzone R; Schwartz O; Naya H; Nan FJ; Li J; Altmeyer R; Zuo JP
Antiviral Res; 2009 Mar; 81(3):239-47. PubMed ID: 19118579
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic helical peptides containing two acridine moieties display picomolar affinity toward HIV-1 RRE and TAR.
Lee Y; Hyun S; Kim HJ; Yu J
Angew Chem Int Ed Engl; 2008; 47(1):134-7. PubMed ID: 17987636
[No Abstract] [Full Text] [Related]
19. Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro.
Pang W; Wang RR; Yang LM; Liu CM; Tien P; Zheng YT
Virology; 2008 Jul; 377(1):80-7. PubMed ID: 18499209
[TBL] [Abstract][Full Text] [Related]
20. Chemistry of HIV-1 virucidal Pt complexes having neglected bidentate sp2 N-donor carrier ligands with linked triazine and pyridine rings. synthesis, NMR spectral features, structure, and reaction with guanosine.
Maheshwari V; Bhattacharyya D; Fronczek FR; Marzilli PA; Marzilli LG
Inorg Chem; 2006 Sep; 45(18):7182-90. PubMed ID: 16933918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
